<DOC>
	<DOCNO>NCT00547612</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , positron emission tomography ( PET ) use [ 18F ] -labeled substance P antagonist receptor quantifier , may effective find disease patient pancreatic cancer . PURPOSE : This phase I trial study well PET scan use [ 18F ] -labeled substance P antagonist receptor quantifier work find disease patient pancreatic cancer .</brief_summary>
	<brief_title>Positron Emission Tomography Using 18F-Labeled Substance P Antagonist Receptor Quantifier Finding Disease Patients With Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether [ 18F ] -labeled substance P antagonist receptor quantifier positron emission tomography identify pancreatic cancer evident multiphase CT scan . OUTLINE : Patients undergo multiphase CT scan chest , abdomen , pelvis . No 15 day later , patient receive [ 18F ] -labeled substance P antagonist receptor quantifier IV undergo positron emission tomography 6 hour . Blood collect periodically measure metabolism radiotracer high performance liquid chromatography radioactive detector .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<mesh_term>( 2-fluoromethoxy-5- ( 5-trifluoromethyltetrazol-1-yl ) benzyl ) ( 2-phenylpiperidin-3-yl ) amine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma pancreas Primary metastatic disease At least one site measurable disease Enrolled NCI protocol ( either treatment screen protocol ) NCI05C0044 NCI05C0141 PATIENT CHARACTERISTICS : Inclusion criterion : ECOG performance status 02 WBC ≥ 1,200/mm³ Creatinine &lt; 2.0 mg/dL Negative pregnancy test Fertile patient must agree use effective contraception Not pregnant nursing Exclusion criterion : Allergy IV contrast Claustrophobia would preclude completion scan unable lie one 's back positron emission tomography scan PRIOR CONCURRENT THERAPY : Inclusion criterion : More 4 week since prior abdominal surgery Exclusion criterion : Prior participation research protocol within past year radiation exposure together present study would exceed annual limit Aprepitant within 72 hour [ 18F ] label substance P antagonist receptor quantifier positron emission tomography</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
</DOC>